Lv4
730 积分 2022-02-15 加入
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy
17天前
已完结
Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis
1个月前
已完结
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
4个月前
已完结
Tonic signaling in CAR-T therapy: the lever long enough to move the planet
4个月前
已完结
Phase 1/2 Trial of Anti-CD7 Allogeneic WU-CART-007 in patients with Relapsed/Refractory T-cell Malignancies
5个月前
已完结
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors
6个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
8个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
8个月前
已完结
皖公网安备34019202002308
